Feasibility of a Web-based, Peer-supported Exercise Program for Patients With Hip and/or Knee Osteoarthritis (AktiWeb)

September 21, 2022 updated by: Anne Therese Tveter, Diakonhjemmet Hospital
In this project, a web-based exercise program is developed in co-creation between specialized health care, the Norwegian Association for Rheumatic diseases (NRF) and a group of experienced patient representatives. The project emerges from the evidence that exercise is recommended as first-line treatment for patients with chronic diseases like hip- and knee-osteoarthritis (OA). However, the number of patients in need of targeted exercise will increase considerably the next decades, and their treatment needs cannot be fully handled within the health care system. Development of innovative and effective treatment trajectories and follow-up strategies is urgently required. Peer-support is recognized as an effective way to increase patients' long-term adherence to exercise. Thus, patient-organizations may be an unutilized resource in support and follow-up of patients who need long-term exercise as part of their treatment plan. After discharge from examination in hospital, patients with hip/knee OA will be recruited to follow-up in a novel web-based, peer-supported exercise program, and the feasibility of the intervention will be evaluated.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The study will be conducted as a pre-post single-arm feasibility study comprising 50 participants.

The main objective of the study will be to evaluate the feasibility of the web-based, peer-supported exercise intervention in patients with hip and/or knee OA.

Specific research objectives are:

  • to assess feasibility of intervention delivery, data collection, eligibility and inclusion/exclusion criteria and intervention fidelity
  • to assess the responsiveness of relevant primary and secondary outcome measures

In the feasibility study, all participants will be allocated to an intervention group, receiving a 12-week web-based, peer-supported aerobic exercise program including weekly motivational messages. Patients between 40 and 80 years of age that are not candidates for surgery will be recruited from Diakonhjemmet Hospital, Oslo, Norway.

To assess and evaluate feasibility, we will report on descriptive statistics. Responsiveness will be assessed using Receiver Operating Curve (ROC) analyses.

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0319
        • Diakonhjemmet Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

• patients with hip and/or knee osteoarthritis being referred to Diakonhjemmet Hospital

Exclusion Criteria:

  • candidate for surgery
  • unable to understand or write Norwegian
  • unable to walk unaided and continuously for 15 minutes
  • absolute or relative contradictions to maximal exercise testing
  • have relatives with sudden death before 40 years of age
  • have first-degree relatives with hypertrophic cardiomyopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Participants allocated to the intervention group will be familiarized with exercise intensity levels (heart rate and Borg RPE) during the assessment at Diakonhjemmet Hospital. Further, the patients will be offered to take part in a 5-hour Learning and Mastery-course at Diakonhjemmet Hospital. Thereafter, the participants will get access to a web-based exercise program and guided to choose the appropriate exercise-level. Weekly, based on the individual progression, all participants will receive an exercise program by email consisting of individually tailored exercise sessions and motivational messages. At the end of each week, the participants complete an electronic exercise diary for monitoring adherence. All participants will be offered the possibility to seek peer-support; however, if preferred they may also follow the exercise program by themselves.
Participants will be offered to take part in a 5-hour Learning and Mastery-course at Diakonhjemmet Hospital, receiving information about the osteoarthritis disease, symptoms and the importance of exercise and physical activity. Participants will then be given a weekly web-based exercise program (12 weeks) consisting of three aerobic exercise sessions per week. The exercise program consists of five levels, and the participants will each week be guided to the most appropriate level based on their measured physical fitness level and the weekly exercise diary. The participants will at initial assessment at Diakonhjemmet Hospital be instructed to use Borgs scale to adjust exercise level. Based on the weekly exercise diary the participants will also get motivational messages by email.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility: time resources used by peer-supporters
Time Frame: baseline to 12 weeks
Time (hours/minutes) per participant-peer-support contact (frequency of contacts divided by total time used by peer-supporters).
baseline to 12 weeks
Feasibility: time resources used on the exercise program delivery
Time Frame: baseline to 12 weeks
Time (hours/minutes) per week per participant used on web-based exercise program delivery.
baseline to 12 weeks
Feasibility: time resources used on motivational messages delivery
Time Frame: baseline to 12 weeks
Time (hours/minutes) per week per participant used on motivational message delivery.
baseline to 12 weeks
Feasibility: proportion of received exercise diaries
Time Frame: baseline to 12 weeks
Proportion of received exercise diaries (0-12 per participant).
baseline to 12 weeks
Feasibility: proportion wearing the activity monitor
Time Frame: baseline
Proportion of participants providing activity monitor data (at least 4 days, including one weekend day, with minimum 10 hours recording per day) at baseline.
baseline
Feasibility: proportion completing treadmill test
Time Frame: baseline
Proportion of participants completing the indirect maximal cardiorespiratory exercise test according to test-protocol at baseline.
baseline
Eligible: proportion eligible
Time Frame: baseline
Proportion of potentially eligible participants approached that are invited.
baseline
Recruitment: proportion enrolled
Time Frame: baseline
Proportion of eligible patients enrolled.
baseline
Retention: proportion of enrolled participants
Time Frame: baseline and 12 weeks
Proportion of enrolled participants providing data at 12 week post-test.
baseline and 12 weeks
Adverse events: number of adverse events
Time Frame: 12 weeks
Total number of adverse events (by cause if possible) evaluated by answers at post-test: The four questions addressing possible adverse events: 1) Have you carried out any type of treatment during the last 3 months? (With treatment we mean medication, physical exercise, self-management course or any alternative treatments) (yes/no), 2) If yes, have you experienced any adverse event as a result of the treatment? (yes/no). 3) If yes, which adverse events as a result of treatment? 4) In your opinion, which treatment(s) do you think the adverse event was/were caused by? (medication, physical exercise, self-management course, alternative treatments, other) (Elaborate).
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in objectively measured physical activity
Time Frame: baseline and 12 weeks
Assessed by accelerometer (ActiGraph GT3X+): Change in physical activity level measured as counts per minute (CPM), which is the total number of registered counts for all valid days divided by wear time. Thresholds for CPM will be used in calculation of time (minutes per week/day) spent on sitting (<100 CPM), and on light (100-2019 CPM), moderate-(>2019-5998 CPM) and vigorous (>5998) intensity physical activity.
baseline and 12 weeks
Change in physical fitness (VO2 peak)
Time Frame: baseline and 12 weeks
Change in VO2 peak measured by indirect maximal cardiorespiratory exercise test (modified Balke-protocol). The indirect estimation of VO2 peak by prediction equations is based on incline, grade and speed at end stage, weight and age.
baseline and 12 weeks
Change in Hip disability and Osteoarthritis Outcome Score (HOOS)
Time Frame: baseline and 12 weeks
Change in the last week disability on five subscales; pain (10 items, scale 0-40), symptoms (5 items, scale 0-20), function in daily living (17 items, scale 0-68), function in sport and recreation (4 items, scale 0-16) and quality of life (4 items, scale 0-16). Items are scored by a five-point Likert scale ranging from 0 (least severe) to 4 (most severe). Total sum-score and subscale sum-scores will be converted to normalized scores ranging from 0 (extreme disability) to 100 (no disability).
baseline and 12 weeks
Change in Knee disability and Osteoarthritis Outcome Score (KOOS)
Time Frame: baseline and 12 weeks
Change in the last week disability on five subscales; pain (9 items, scale 0-36), symptoms (7 items, scale 0-28), function in daily living (17 items, scale 0-68), function in sport and recreation (5 items, scale 0-20) and quality of life (4 items, scale 0-16). Items are scored by a five-point Likert scale ranging from 0 (least severe) to 4 (most severe). Total sum-score and subscale sum-scores will be converted to normalized scores ranging from 0 (extreme disability) to 100 (no disability).
baseline and 12 weeks
Change in Patient-specific functional scale (PSFS)
Time Frame: baseline and 12 weeks
Patients will address one to three activities they have problems performing due to osteoarthritis. The degree of difficulty with performing these activities is rated from 0 (cannot perform the activity) to 10 (no problems).
baseline and 12 weeks
Change in self-reported physical activity (International Physical Activity Questionnaire-Short Form)
Time Frame: baseline and 12 weeks
Measured by The International Physical Activity Questionnaire-Short Form: Change in time (minutes per week/day) and Metabolic Equivalent of Task (MET-minutes per week/day) spent on sitting, walking, and moderate- and vigorous intensity physical activity the last week (0-7 days). METs are calculated by using the corresponding MET-values for walking (3.3 MET), and moderate-(4.0 MET) and vigorous (8.0 MET) intensity physical activity.
baseline and 12 weeks
Change in self-reported physical activity (HUNT)
Time Frame: baseline and 12 weeks
Measured by the three questions from the Nord-Trøndelag Health study (HUNT): change in average frequency (never/<1 per week/1 per week/2-3 per week/almost every day), intensity (easy without losing my breath or breaking into a sweat/so hard that I lose my breath and break into a sweat/I push myself to near-exhaustion) and duration (less than 15 minutes/15-29 minutes/30 minutes to 1 hour/more than 1 hour) of physical activity.
baseline and 12 weeks
Change in self-reported pain intensity the last week
Time Frame: baseline and 12 weeks
Measured by numeric rating scale ranging from 0 (no pain) to 10 (worst pain).
baseline and 12 weeks
Change in self-reported fatigue the last week
Time Frame: baseline and 12 weeks
Measured by numeric rating scale ranging from 0 (no fatigue) to 10 (worst fatigue).
baseline and 12 weeks
Change in self-reported disease activity the last week
Time Frame: baseline and 12 weeks
Measured by numeric rating scale ranging from 0 (good, no symptoms) to 10 (very bad, much symptoms).
baseline and 12 weeks
Change in Health-related quality of life (EQ-5D-5L)
Time Frame: baseline and 12 weeks
EQ-5D-5L will be used for measuring health-related quality of life (www.euroqol.org): comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels of answers (no problems, slight problems, moderate problems, severe problems, and extreme problems). The average score on each dimension will be reported, and the total score can be calculated into an index value ranging from -0.59 to 1, where -0.59 represents worst possible state and 1 represents perfect health.
baseline and 12 weeks
Change in Arthritis Self-Efficacy Scale (ASES)
Time Frame: baseline and 12 weeks
Measured by Arthritis Self-Efficacy Scale (ASES): comprises 11 items addressing pain and symptoms (scored on a 5-point scale ranging from not confident at all to very confident). The scores are summed up to a 0-100 score where higher score indicate better self-efficacy.
baseline and 12 weeks
Change in exercise self-efficacy
Time Frame: baseline and 12 weeks
Measured by Exercise Beliefs and Exercise Habits questionnaire: comprises 20 items addressing exercise self-efficacy (4 items), barriers to exercise (3 items), benefits of exercise (5 items), and impact of exercise on arthritis (8 items), scored on a 5-point Likert scale ranging from strongly disagree to strongly agree. The scores on each subscale is summed up where higher scores indicate better self-efficacy.
baseline and 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant fidelity: proportion attending learning and mastery-course
Time Frame: baseline to 12 weeks
Proportion of enrolled participants attending a 5-hour osteoarthritis learning and mastery-course (attendance registered by yes/no).
baseline to 12 weeks
Participant fidelity (adherence): frequency of exercise
Time Frame: baseline to 12 weeks
Total number of exercise sessions.
baseline to 12 weeks
Participant fidelity (adherence): frequency of exercise per week
Time Frame: baseline to 12 weeks
Average number of exercise sessions per week.
baseline to 12 weeks
Participant fidelity (adherence): frequency of exercise weeks
Time Frame: baseline to 12 weeks
Total number of weeks with minimum one exercise session.
baseline to 12 weeks
Participant fidelity (adherence): duration of exercise sessions
Time Frame: baseline to 12 weeks
Total number of exercise sessions completed according to prescribed duration. Measured by a question about completion of the prescribed exercise-session (yes/no).
baseline to 12 weeks
Participant fidelity (adherence): intensity of exercise sessions
Time Frame: baseline to 12 weeks
Total number of exercise sessions completed according to prescribed intensity. Measured by self-reported Rating of Perceived Exertion Scale (Borg RPE) ranging from 6 (resting) to 20 (maximal intensity).
baseline to 12 weeks
Use of health care resources due to musculoskeletal pain
Time Frame: baseline
Registered by self-report: 1) frequency (number of consultations the last 6 months) with a general practitioner and specialist health care (rheumatologist, orthopedist, neurologist, other), 2) referred (yes/no, the last 6 months) to x-ray, magnetic resonance imaging, physiotherapist, healthy life center, occupational therapist, 3) frequency (number of consultations during the last 6 months) with a physiotherapist, manual therapist, chiropractor, alternative treatment, other due, 4) had a stay at a rehabilitation institution during the last 6 months (yes/no and number of days). Descriptive data will be reported.
baseline
Use of medication due to musculoskeletal pain
Time Frame: baseline
Registered by self-report: Frequency (never/<1 per month/monthly/weekly/daily/several times per day) of medication use (addressing pain, sleeping, depression, anxiety) the last 3 months will be self-reported through type, name and dosage (mg) of medication, in addition to use of other medication (yes/no) and type. Descriptive data will be reported.
baseline
Osteoarthritis pain on a Global Rating of Change scale
Time Frame: 12 weeks
Change in osteoarthritis pain (from baseline to post-test) measured by a 7-point Global Rating of Change scale ranging from -3 (much worse) to +3 (much better).
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne Therese Tveter, PhD, National Resource Center on Research in Rheumatology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2019

Primary Completion (Actual)

June 1, 2020

Study Completion (Actual)

June 1, 2020

Study Registration Dates

First Submitted

August 21, 2019

First Submitted That Met QC Criteria

September 7, 2019

First Posted (Actual)

September 10, 2019

Study Record Updates

Last Update Posted (Actual)

September 22, 2022

Last Update Submitted That Met QC Criteria

September 21, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2018/2198-feasibility

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data can possibly be made available on request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Clinical Trials on Exercise

3
Subscribe